Evidence map›Paper›PMID 36323858›Full record

ArticleCommunications biology2022

Author Correction: Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture.

Zixuan Yuan, Mahmud Arif Pavel, Hao Wang, Jerome C Kwachukwu, Sonia Mediouni, Joseph Anthony Jablonski, Kendall W Nettles, Chakravarthy B Reddy, Susana T Valente, Scott B Hansen

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zixuan Yuan *Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, 33458, USA.ORCID http://orcid.org/0000-0003-0665-5086
Mahmud Arif Pavel *Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, 33458, USA.
Hao WangDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, 33458, USA.
Jerome C KwachukwuDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, FL, 33458, USA.ORCID http://orcid.org/0000-0003-4313-9187
Sonia MediouniDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL, 33458, USA.
Joseph Anthony JablonskiDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL, 33458, USA.
Kendall W NettlesDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, FL, 33458, USA.ORCID http://orcid.org/0000-0003-2917-7574
Chakravarthy B ReddyDepartment of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT, 84112, USA.
Susana T ValenteDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL, 33458, USA.
Scott B HansenDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, 33458, USA. shansen@scripps.edu.ORCID http://orcid.org/0000-0003-0086-9753
Scripps Research Institute · USUniversity of Utah · US

Funding

The role of lipid raft disruption in the activation of TREK-1 channels by anestheticsR01NS112534 · NINDS · UNIVERSITY OF FLORIDA · PI HANSEN, SCOTT B · 2019 to 2023
$2.2M
NINDS NIH HHS R01 NS112534
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36323858
PMCPMC9628440
OpenAlexW4307922492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.